Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0H5HJ
|
||||
| Former ID |
DPR000169
|
||||
| Drug Name |
ALN-PCS
|
||||
| Drug Type |
RNAi therapeutics
|
||||
| Indication | Hypercholesterolemia [ICD10:E78] | Preclinical | [550232] | ||
| Company |
Alnylam Pharmaceuticals
|
||||
| Target and Pathway | |||||
| Target(s) | mRNA of proprotein convertase subtilisin/kexin type 9 | Target Info | [550232] | ||
| WikiPathways | PCSK9-mediated LDLR degradation | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.